We confirmed these findings by measuring TPC2 currents using endolysosomal patch-clamp electrophysiology in different cancer lines, revealing that currents are much larger in SK-MEL-5 (melanoma line with high TPC2/Rab7a levels in qPCR experiments) as compared to HeLa or MDA-MB-231 cells (low TPC2/Rab7a levels in qPCR experiments) (Fig. S1a). This evidence concerns the gene RAB7A and melanoma.